Open-label, single-group pilot (n=30) testing one oral psilocybin session combined with ten-session manualised group psychotherapy for demoralization in long-term AIDS survivors.
Open-label mixed-methods pilot of one individual oral psilocybin session combined with ten twice-weekly sessions of manualised brief Supportive-Expressive Group Therapy for existential distress in long-term AIDS survivors.
Primary aim was feasibility and safety; outcomes included measures of demoralization, distress and depression with qualitative assessments embedded.
Modified brief Supportive-Expressive Group Therapy (ten twice-weekly sessions) plus one individual oral psilocybin session.
One individual oral psilocybin treatment session; dose not stated in registry fragment.
Modified brief Supportive-Expressive Group Therapy: manualised, twice-weekly group sessions
This follow-up study (n=18) to Anderson and colleagues (2020) finds that attachment anxiety, but not attachment avoidance, decreased significantly 3 months after psilocybin-assisted group therapy.